A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV.

Autor: Wilck M; Merck & Co., Inc., Rahway, New Jersey, USA., Barnabas S; Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa., Chokephaibulkit K; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Violari A; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Kosalaraksa P; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Yesypenko S; Odesa Regional Center for Socially Significant Diseases, Odeska Oblast., Chukhalova I; Dnipropetrovsk Regional Medical Center Of Socially Significant Diseases, Dnipro, Ukraine., Dagan R; The Shraga Segal Department of Microbiology, Immunology and Genetics Faculty of Health Sciences of the Ben-Gurion University of the Negev Beer-Sheva, Israel., Richmond P; University of Western Australia, Perth, Australia., Mikviman E; Merck & Co., Inc., Rahway, New Jersey, USA., Morgan L; Merck & Co., Inc., Rahway, New Jersey, USA., Feemster K; Merck & Co., Inc., Rahway, New Jersey, USA., Lupinacci R; Merck & Co., Inc., Rahway, New Jersey, USA., Chiarappa J; Merck & Co., Inc., Rahway, New Jersey, USA., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Bickham K; Merck & Co., Inc., Rahway, New Jersey, USA., Musey L; Merck & Co., Inc., Rahway, New Jersey, USA.

Publikováno v: AIDS (London, England) [AIDS] 2023 Jul 01; Vol. 37 (8), pp. 1227-1237. Date of Electronic Publication: 2023 Mar 17.

Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review.

Autor: Khan S; RTI Health Solutions, Research Triangle Park, North Carolina., Rupniewska E; RTI Health Solutions, Research Triangle Park, North Carolina., Neighbors M; RTI Health Solutions, Research Triangle Park, North Carolina., Singer D; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania., Chiarappa J; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania., Obando C; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania.

Publikováno v: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2019 Aug; Vol. 44 (4), pp. 495-507. Date of Electronic Publication: 2019 Mar 14.

Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis.

Autor: Zhdanava, Maryia (AUTHOR), Kachroo, Sumesh (AUTHOR), Shah, Aditi (AUTHOR), Ding, Zhijie (AUTHOR), Lefebvre, Patrick (AUTHOR), Zhao, Ruizhi (AUTHOR), Kerner, Caroline (AUTHOR), Pilon, Dominic (AUTHOR)

Publikováno v: Patient Preference & Adherence. Apr2024, Vol. 18, p809-820. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.